While All-Stars Jalen Brunson and Karl-Anthony Towns garner most of the headlines for the New York Knicks (and rightfully so, given their performance this year), another player on the roster could ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...

The 2025 NFL season is more than halfway complete with Week 10 in the books and Week 11 already upon us. The playoff picture isn't finalized, but it's certainly taking shape as we near the home ...

At launch, Black Ops 7 will feature nine Wildcards. These unique abilities are designed to ultimately change how you plan and build your loadout, as certain Wildcards allow you to spawn with extra ...

Pacira BioSciences faces significant risk as generic challenges threaten Exparel, its flagship product responsible for 78% of 2024 revenue. PCRX's complex formulation, robust patent estate, and ...

Trading card manufacturer Wild Card filed a lawsuit Thursday alleging rival card maker Panini America violated federal and Texas antitrust laws. Wild Card’s lawsuit alleges Panini has been ...

Panini America has been named the defendant in a lawsuit filed by Wild Card in a court filing that was filed today. The briefing outlines accusations of violating federal laws such as the Sherman Anti ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...